|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
108.15(B) |
Last
Volume: |
4,786,595 |
Avg
Vol: |
8,429,684 |
52
Week Range: |
$48.64 - $75.67 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
250,541 |
430,874 |
929,865 |
2,041,378 |
Total Sell Value |
$18,359,902 |
$29,055,549 |
$55,374,067 |
$104,875,147 |
Total People Sold |
9 |
10 |
11 |
13 |
Total Sell Transactions |
14 |
25 |
42 |
77 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Brennan Daniel J. |
EVP and CFO |
|
2024-05-23 |
4 |
AS |
$75.11 |
$3,576,932 |
D/D |
(47,621) |
223,921 |
|
2% |
|
Brennan Daniel J. |
EVP and CFO |
|
2024-05-22 |
4 |
AS |
$75.91 |
$4,892,819 |
D/D |
(64,454) |
271,542 |
|
0% |
|
Brennan Daniel J. |
EVP and CFO |
|
2024-05-22 |
4 |
OE |
$16.31 |
$1,374,836 |
D/D |
64,454 |
335,996 |
|
- |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2024-05-22 |
4 |
AS |
$76.01 |
$1,140,633 |
D/D |
(15,006) |
32,326 |
|
0% |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2024-05-22 |
4 |
OE |
$27.09 |
$406,513 |
D/D |
15,006 |
47,332 |
|
- |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2024-05-21 |
4 |
AS |
$75.60 |
$1,363,606 |
D/D |
(18,037) |
32,326 |
|
-0% |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2024-05-21 |
4 |
OE |
$24.55 |
$442,808 |
D/D |
18,037 |
50,363 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2024-05-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,380 |
190,487 |
|
- |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2024-05-10 |
4 |
S |
$74.14 |
$958,717 |
D/D |
(12,931) |
31,422 |
|
-1% |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2024-05-10 |
4 |
OE |
$16.31 |
$210,905 |
D/D |
12,931 |
44,353 |
|
- |
|
Ludwig Edward J |
Director |
|
2024-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,901 |
44,275 |
|
- |
|
Wichmann David S |
Director |
|
2024-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,901 |
39,501 |
|
- |
|
Dockendorff Charles J |
Director |
|
2024-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,901 |
2,901 |
|
- |
|
Morano Susan E |
Director |
|
2024-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,871 |
3,953 |
|
- |
|
Fujimori Yoshiaki |
Director |
|
2024-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,901 |
2,901 |
|
- |
|
Sununu John E |
Director |
|
2024-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,901 |
52,642 |
|
- |
|
Zane Ellen M |
Director |
|
2024-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,901 |
48,530 |
|
- |
|
Mega Jessica L |
Director |
|
2024-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,901 |
6,154 |
|
- |
|
Dockendorff Charles J |
Director |
|
2024-05-07 |
4 |
AS |
$72.70 |
$286,874 |
D/D |
(3,946) |
0 |
|
3% |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2024-05-02 |
4 |
D |
$72.03 |
$73,255 |
D/D |
(1,017) |
30,022 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2024-05-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,102 |
31,039 |
|
- |
|
Sorenson John Bradley |
EVP, Global Operations |
|
2024-05-02 |
4 |
D |
$72.03 |
$138,082 |
D/D |
(1,917) |
52,924 |
|
- |
|
Sorenson John Bradley |
EVP, Global Operations |
|
2024-05-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,203 |
54,841 |
|
- |
|
Sorenson John Bradley |
EVP, Global Operations |
|
2024-05-01 |
4 |
AS |
$71.50 |
$1,257,488 |
D/D |
(17,587) |
50,638 |
|
5% |
|
Sorenson John Bradley |
EVP, Global Operations |
|
2024-05-01 |
4 |
OE |
$17.26 |
$303,552 |
D/D |
17,587 |
68,225 |
|
- |
|
4534 Records found
|
|
Page 1 of 182 |
|
|